首页> 外国专利> BIOLOGICALLY ACTIVE SUBSTANCE, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HERPETIC INFECTIONS AND UTILIZATION OF SAID BIOLOGICALLY ACTIVE SUBSTANCE

BIOLOGICALLY ACTIVE SUBSTANCE, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HERPETIC INFECTIONS AND UTILIZATION OF SAID BIOLOGICALLY ACTIVE SUBSTANCE

机译:生物活性物质,制备相同的过程,药物组合物,用于治疗疱疹感染和利用所述生物活性物质

摘要

The invention relates to a biologically active substance, to a process for preparing said substance, to a pharmaceutical composition for treating herpetic infections and to the utilization of said biologically active substance. According to the invention, the biologically active substance comprises 4.5 mg Glu/ 100 mg, 1.47 mg Tre/100 mg, 1.27 mg Cer/100 mg, 1.53 mg Pro/100 mg, 0.25 mg Cis/ 100 mg, 1.39 mg Gly/ 100 mg, 1.71 mg Ala/ 100 mg, 1.24 mg Val/ 100 mg, 0.10 mg Met/ 100 mg, 1. 26 mg Izo/ 100 mg, 1.77 mg :Ley/ 100 mg, 1.11 mg Pir/ 100 mg, 3.17 mg Fen/ 100 mg, 2. 99 mg Asp/ 100 mg, 1.99 mg Arg/ 100 mg, 0.63 mg His/ 100 mg, 0.12 mg Tri / 100 mg. The process for preparing the biologically active substance consists in the steps of: a) growing on a large scale the Galeria mellonella insect in artificial culturing environments, under laboratory conditions; b) selecting one kilo of larvae in a last stadium of development, when insects do not feed themselves and their intestine becomes sterile; c) disinfecting the larvae surface with a detergent in a concentration of 15 ... 20 ml to 2 l of warm water at a temperature ranging from 30 to 35 degree C, washing the larvae three-four times, rinsing the larvae two-three times with double distilled water, subjecting the surface of the bodies of the larvae to UV radiation from a distance of 1 to 1.5 m for 2 to 2.5 min for a total disinfection; d) grinding the sterile larvae for 10 to 15 min till an homogeneous mass of grey light colour is obtained; e) filtering the suspension by means of a very fine mesh with orifices ranging from 200-300 micro in order to remove the larvae tissues remaining from the grinding; f) centrifuging the suspension at a speed of 5, 000 -5, 500 rpm, for 30 -35 min until there do not settle all the proteins any longer; g) lyophilizing or atomizing the suspension at a temperature ranging from -150 ... 160 degree C or at a temperature ranging from 170 ... 180 degree C at the input and 85 ...90 degree C at the output; h) collecting 250 g dry powder and preserving the same at a temperature ranging from 15 to 20 degree C.
机译:本发明涉及一种生物活性物质,涉及一种制备该物质的方法,涉及一种治疗疱疹感染的药物组合物,并涉及所述生物活性物质的利用。根据本发明,生物活性物质包含4.5 mg Glu / 100 mg,1.47 mg Tre / 100 mg,1.27 mg Cer / 100 mg,1.53 mg Pro / 100 mg,0.25 mg Cis / 100 mg,1.39 mg Gly / 100毫克,1.71毫克Ala / 100毫克,1.24毫克Val / 100毫克,0.10毫克Met / 100毫克,1.26毫克Izo / 100毫克,1.77毫克:Ley / 100毫克,1.11毫克Pir / 100毫克,3.17毫克芬/ 100 mg,2。99 mg Asp / 100 mg,1.99 mg Arg / 100 mg,0.63 mg His / 100 mg,0.12 mg Tri / 100 mg。制备生物活性物质的方法包括以下步骤:a)在实验室条件下,在人工培养环境中大规模生长梅花Gal虫。 b)在昆虫无法自给自足且肠道变得无菌的情况下,在最后的发育场中选择一公斤幼虫; c)在30至35摄氏度的温度下,用浓度为15 ... 20 ml至2 l的温水的洗涤剂对幼虫表面进行消毒,将幼虫洗三到四次,然后将幼虫冲洗三到三遍用两次蒸馏水消毒两次,使幼虫的身体表面从1到1.5 m的距离经受紫外线照射2到2.5分钟,以进行完全消毒; d)将无菌幼虫研磨10至15分钟,直到获得均匀的灰色浅色团; e)用一个非常细的网眼过滤悬浮液,该网眼的孔径在200-300微米之间,以除去研磨中残留的幼虫组织; f)以5,000 -5,500 rpm的速度离心悬浮液30 -35分钟,直到不再溶解所有蛋白质为止; g)在-150℃至160℃的温度范围内或在输入端170℃至180℃的温度下以及在输出端85℃至90℃的温度下冻干或雾化悬浮液; h)收集250克干粉,并将其保存在15至20摄氏度的温度下。

著录项

  • 公开/公告号RO118114B

    专利类型

  • 公开/公告日2003-02-28

    原文格式PDF

  • 申请/专利权人 CIUHRII MIRCEA BUCURESTI;

    申请/专利号RO20000000579

  • 发明设计人 CIUHRII MIRCEA;

    申请日2000-06-06

  • 分类号A61K35/64;

  • 国家 RO

  • 入库时间 2022-08-22 00:01:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号